Search
Close this search box.
Search
Close this search box.

Cyprus Enhances Healthcare System Resilience for Future Challenges

Nicosia: Cyprus has introduced a series of measures to modernize and digitize its health systems and infrastructure, aiming to bolster the resilience of its healthcare system against future health threats, stated Health Minister Michalis Damianou. The announcement was made during a panel discussion at the 2025 Cyprus Diaspora Forum, titled “The Future of Healthcare – Changes Transforming Cyprus Healthcare Industry”.

According to Cyprus News Agency, the Minister highlighted the necessity of strengthening and advancing the health sector in Cyprus in light of rapid global developments and the need for constant adaptation to international conditions. He emphasized that this is not merely a desire but a necessity for the nation.

The Minister discussed the implementation of a new, integrated General Healthcare System, which merges the public and private sectors into a unified, competitive healthcare market, introducing significant changes across all system areas. Damianou also stressed that attracting and supporting investment in healthcare not only enhances patient conditions but also contributes to the country’s economic and social development.

In his address, the Minister outlined the Health Capacity Master Plan, which is projected over at least ten years. This plan aims to fortify the Ministry and other healthcare stakeholders’ ability to plan effectively and make informed decisions to meet both current and future healthcare needs.

Damianou described the Health Axis of the Cyprus Recovery and Resilience Plan 2021-2026, which includes modernizing and digitalizing healthcare infrastructure, purchasing and replacing medical equipment in hospitals, accrediting public and private hospitals, and establishing a National Centre for Clinical Evidence and Quality Improvement. These interventions are designed to enhance, modernize, and upgrade state hospitals.

Regarding pharmaceuticals, the Minister mentioned a recent EU regulation aimed at promoting innovation and research by facilitating larger, multinational clinical trials across EU and EEA countries. He noted that this strengthens Cyprus as a favorable location for clinical research, supported by the rapid growth of academic institutions in health and medical fields.

Damianou emphasized the importance of vigilance within the Ministry, highlighting the need to invest in data collection and analysis, embrace technological solutions, cross-train a skilled workforce, and develop infrastructure to meet high-risk medical needs. He also pointed out the necessity for efficient inventory management of equipment and medicines to create a sustainable healthcare model capable of responding to crises with minimal disruption.